ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.931,29
0,05%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,06972
-0,19%
Bitcoin
57.629,67
-1,04%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) News

AGIO Agios Pharmaceuticals Inc

33,66
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Agios Pharmaceuticals Inc AGIO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 33,66 10:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
33,66
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202413:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09.4.202413:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
08.3.202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202413:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
01.3.202422:27EDGAR2Form 144 - Report of proposed sale of securities
01.3.202422:26EDGAR2Form 144 - Report of proposed sale of securities
01.3.202422:25EDGAR2Form 144 - Report of proposed sale of securities
01.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202403:21EDGAR2Form 144 - Report of proposed sale of securities
22.2.202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202413:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
15.2.202416:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202413:03EDGAR2Form 8-K - Current report
15.2.202413:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
14.2.202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202420:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02.2.202413:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
24.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202413:58EDGAR2Form 8-K - Current report
08.1.202413:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
05.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202412:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02.1.202413:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
10.12.202301:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20.11.202313:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02.11.202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202314:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02.11.202312:02EDGAR2Form 8-K - Current report
02.11.202312:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
28.9.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202313:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
21.8.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
AGIO
Agios Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten